Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 2236 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. 2022-06-28
Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. 2022-06-21
Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". 2022-06-21
Galapagos N.V.. (6/21/22). "Press Release: Galapagos to Acquire CellPoint and AboundBio to Accelerate Access to Next-generation Cell Therapies". Mechelen, Leiden & Pittsburgh, PA. 2022-06-21
Genomatica, Inc.. (6/16/22). "Press Release: Geno and Unilever Launch $120m Venture to Scale Alternative to Palm Oil and Fossil Fuels". San Diego, CA & London. 2022-06-16
Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. 2022-06-15
High-Tech Gründerfonds Management GmbH. (6/14/22). "Press Release: Over €400 Million. New High-Tech Gründerfonds Seed Fund Exceeds Expectations". Bonn. 2022-06-14
Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg. 2022-06-14
ImCheck Therapeutics S.A.S.. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immuno 2022-06-13
CimCure. (6/21/22). "Press Release: Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures". 2022-06-10
Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge. 2022-06-09
Ziphius Vaccines N.V.. (6/9/22). "Press Release: Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics". 2022-06-09
Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. 2022-06-09
Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. 2022-06-08
ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. 2022-06-07
Vizgen Inc.. (6/3/22). "Press Release: Vizgen Announces $85.2 Million Series C Financing". Cambridge, MA. 2022-06-03
DSM N.V.. (6/2/22). "Press Release: DSM and Firmenich to Merge, Becoming the Leading Creation and Innovation Partner in Nutrition, Beauty and Well-being [NOT FOR RELEASE WHERE VIOLATION OF LAW]". Vienna. 2022-06-02
Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. 2022-06-02
Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY. 2022-06-02
Immunic, Inc.. (6/2/22). "Press Release: Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate Update". New York, NY. 2022-06-02
Minoryx Therapeutics S.L.. (5/31/22). "Press Release: Minoryx Raises €51 Million to Support Marketing Authorization Application and Launch Preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy". Mataró, Barcelona. 2022-05-31
Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. 2022-05-31
BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg. 2022-05-30
CureVac N.V.. (5/25/22). "Press Release: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development". Tübingen & Ghent. 2022-05-25
Alithea Genomics. (5/24/22). "Press Release: Alithea Genomics Raises CHF 1 Million in Seed Financing Round led by Novalis Biotech". Lausanne. 2022-05-24
NLC Ventures Netherlands B.V.. (5/23/22). "Press Release: Allergios Closes Their Latest Round of Seed Financing". 2022-05-23
Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. 2022-05-19
FlandersBio. (5/18/22). "Press Release: Flanders.Bio Appoints CEO and COO in Newly Created Role". 2022-05-18
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. 2022-05-18
Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. 2022-05-17
Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. 2022-05-16
Valneva S.E.. (5/16/22). "Press Release: Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement". Saint-Herblain. 2022-05-16
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert. 2022-05-12
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. 2022-05-11
NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. 2022-05-09
European Spatial Biology Center (ESBC). (5/4/22). "Press Release: The European Spatial Biology Center (ESBC). State-of-the-Art Spatial Biology Services Enabled at Scale in Leuven". 2022-05-04
Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich. 2022-05-03
Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. 2022-05-03
Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. 2022-05-03
Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert. 2022-04-29
Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies. 2022-04-27
Toulouse White Biotech (TWB). (4/27/22). "Press Release: TWB Expands Its Industrial Biotechnology Solutions by Partnering with Processium and Syngulon". London & Gosselies. 2022-04-27
Symeres. (4/26/22). "Press Release: Symeres Acquires Organix Inc., Adding Lipids Expertise and a Strategic Foothold in the US". Nijmegen. 2022-04-26
Mainz Biomed N.V.. (4/26/22). "Press Release: Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer". Berkeley, CA & Mainz. 2022-04-26
ProteoNic. (4/26/22). "Press Release: ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies". Leiden. 2022-04-26
Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham. 2022-04-26
Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam. 2022-04-25
BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London. 2022-04-25
Stentit B.V.. (4/25/22). "Press Release: MedTech Company Stentit Raises €1.8 Million in Seed Round". Eindhoven. 2022-04-25
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. 2022-04-21
NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate". 2022-04-20
VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". 2022-04-20
Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. 2022-04-13
Monkeys not Donkeys. (4/13/22). "Press Release: Quality by Design (QbD) Acquires Marketing & Communication Agency ‘Monkeys not Donkeys’ to Strengthen Its Services within the Life Science Industry". Wilrijk & Ghent. 2022-04-13
Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. 2022-04-12
Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert. 2022-04-12
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. 2022-04-11
Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. 2022-04-10
Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. 2022-04-08
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". 2022-04-04
Forbion Capital Partners. (3/31/22). "Press Release: Forbion Appoints Both Dr Ton Logtenberg and Dr Michael Hayden as Venture Partners". Naarden. 2022-03-31
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. 2022-03-31
V-Bio Ventures. (3/31/22). "Press Release: V-Bio Ventures Raises EUR 110 Million for its Second Fund and Expands Team". Ghent. 2022-03-31
Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". 2022-03-31
Avantium N.V.. (3/31/22). "Press Release: Avantium Reaches Financial Close for its FDCA Flagship Plant". Amsterdam. 2022-03-31
miDiagnostics N.V.. (3/30/22). "Press Release: miDiagnostics Welcomes Nicolas De Clercq as Its New Chief Financial Officer". Leuven. 2022-03-30
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. 2022-03-30
Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London". 2022-03-30
Bone Therapeutics S.A.. (3/29/22). "Press Release: Bone Therapeutics to Strategically Focus on Lead Cell Therapy Product ALLOB". Mont-Saint-Guibert. 2022-03-29
Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". 2022-03-29
Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. 2022-03-29
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
ImmunoPrecise Antibodies Ltd.. (3/29/22). "Press Release: IPA Announces Agreement to Acquire BioStrand BV". Victoria, BC. 2022-03-29
Diadem S.p.A.. (3/28/22). "Press Release: Diadem Announces First Closing of €10 Million Equity Financing for Its AlzoSure Predict Prognostic Blood Test for Alzheimer’s Disease". Milan. 2022-03-28
Argenx SE. (3/23/22). "Press Release: Argenx Raises $700 Million in Gross Proceeds in a Global Offering". Breda. 2022-03-23
Qbic. (3/17/22). "Press Release: Qbic Establishes Third Fund. Qbic Announces First Close of New Fund at € 49 Million to Invest in Spin-offs from World-class Knowledge Partners". St-Denijs-Westrem. 2022-03-17
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. 2022-03-16
Precirix N.V.. (3/16/22). "Press Release: Precirix Raises EUR 80m in Series B to Advance Its Pipeline of Precision Radiopharmaceuticals". Brussels. 2022-03-16
Ryvu Therapeutics S.A.. (3/15/22). "Press Release: Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update". Krakow. 2022-03-15
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. 2022-03-14
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. 2022-03-10
Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. 2022-03-08
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. 2022-03-07
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
European Invesmtent Bank (EIB). (3/7/22). "Press Release: Italy – EIB Provides €7.5 Million Loan for Research and Development of Diadem’s AlzoSure Predict Blood Test for Alzheimer’s disease". 2022-03-07
Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona. 2022-03-04
AbbVie Inc.. (3/1/22). "Press Release: AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio". North Chicago, IL. 2022-03-01
CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. 2022-03-01
ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. 2022-03-01
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. 2022-03-01
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
Ncardia Services B.V.. (2/24/22). "Press Release: Ncardia Appoints Andy Holt as Chief Commercial Officer". Leiden. 2022-02-24
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. 2022-02-23
Complement Therapeutics Ltd.. (2/23/22). "Press Release: Complement Therapeutics Ltd Raises EUR 5 Million Seed Financing by BGV and Forbion and Appoints Dr Rafiq Hasan as CEO". London. 2022-02-23
TargED Biopharmaceuticals B.V.. (2/22/22). "Press Release: TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients". Utrecht. 2022-02-22
SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. 2022-02-16
Newton Biocapital. (2/15/22). "Press Release: Newton Biocapital Launches a New Fund with Initial Capital Commitments of EUR 50 Million and Target Size of EUR 150 Million". Brussels. 2022-02-15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page



Advertisement

Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top